Share Email Print

Proceedings Paper

Novel applications of an adaptive optics visual simulator in the clinical setting
Author(s): Ronald R. Krueger; Alexandra Abdala; Karolinne Rocha; Nicolas Chateau; Laurent Vabre
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Purpose: To evaluate the clinical benefit of using an adaptive optics visual simulator (AOVS) and its impact in different clinical settings. Methods: An adaptive optics visual simulator performed the experimental procedure and was used to optically introduce aberrations in 9 normal eyes for visual acuity (VA) change, and in 10 cyclopleged eyes for enhancing depth of focus (DoF). AOVS was also used to correct 20 highly aberrated eyes. Results: The correction/induction of high order aberrations (HOA) alters the best-corrected visual acuity (BCVA) by a mean of ~1 to 1.5 lines compared to the best spectacle correction. The depth of focus (DoF) was most enhanced (~2.0 D) with the introduction of negative and positive spherical aberration of 0.6 μm magnitude. The correction of HOAs in highly aberrated eyes improved BCVA by a mean of ~1.5 to 2 lines in two groups of pathological eyes. Conclusions: Aberrations have differing effects according to their clinical use. The AOVS defines the clinical response of HOAs on VA, visual perceptions and DoF.

Paper Details

Date Published: 2 March 2010
PDF: 15 pages
Proc. SPIE 7550, Ophthalmic Technologies XX, 755013 (2 March 2010); doi: 10.1117/12.843094
Show Author Affiliations
Ronald R. Krueger, Cole Eye Institute, The Cleveland Clinic Foundation (United States)
Alexandra Abdala, Cole Eye Institute, The Cleveland Clinic Foundation (United States)
Karolinne Rocha, Cole Eye Institute, The Cleveland Clinic Foundation (United States)
Federal Univ. of Sao Paulo (Brazil)
Nicolas Chateau, Imagine Eyes (France)
Laurent Vabre, Imagine Eyes (France)

Published in SPIE Proceedings Vol. 7550:
Ophthalmic Technologies XX
Fabrice Manns; Per G. Söderberg; Arthur Ho, Editor(s)

© SPIE. Terms of Use
Back to Top